Skip to content
Questions regarding the significant profits made by the 340B Drug Pricing Program were raised before the United States Senate Committee on Health, Education, Labor, […]
Fund tracing shows that a reform of 340B is long overdue Read More »
On Feb. 28, 2023, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended approval for Pfizer’s respiratory
FDA’s advisory panel backs GSK’s RSV vaccine Read More »
The 11th International IP Index was published by the U.S. Chamber of Commerce, highlighting the danger of COVID-19 IP infringement and its potential impact
U.S. Chamber’s IP Index highlights progress and new threats Read More »
Acceligen has developed a breed of pigs resistant to the devastating disease Porcine Reproductive and Respiratory Syndrome (PRRS), the Biotechnology Innovation Organization (BIO) member
Acceligen develops new breed of pigs resistant to PRRS Read More »
The Pfizer RSV vaccine candidate for adults over 60 has been recommended by an advisory committee of the Food and Drug Administration (FDA), and
FDA panel recommends Pfizer RSV vaccine for older adults Read More »
Pain is the number one reason most Americans go to the doctor is pain, says Cindy Steinberg, Director of Policy and Advocacy for the
Can biotech crack the code on pain medications? Read More »
For three decades, Genethon, a non-profit research organization, has pioneered development of gene therapies for rare and ultra-rare diseases. Now that our hard work
A significant increase in the percentage of Shigella infections caused by extensively drug-resistant (XDR) versions of the bacteria has prompted the U.S. Centers for
The rise of drug-resistant Shigella offers glimpse into danger AMR poses Read More »
The U.S. Department of Agriculture (USDA) held the 99th Agricultural Outlook Forum last week, where many speakers highlighted the potential of biotechnology and bio-based products.
USDA Agricultural Outlook Forum: SAF, carbon markets, and the future of biotechnology Read More »
According to a recent report from IQVIA, the market for biosimilars, which mimic innovative biologics, is poised to grow this year. Since 2007, a
Biosimilars expected to boom in 2023-27, says report Read More »
